EM574, an erythromycin derivative, is reported to be a GPR38 (motilin receptor) agonist in the human gastric antrum in vitro. This compound was found to stimulate contractions of muscle strips in a concentration dependent manner via displacement of 125I-motilin bound to smooth muscle homogenates. Experiments have shown that EM574 contains the ability to stimulate cholinergic neurons in a non-vagal pathway. Additionally, this agent has been noted to have orexigenic activity with affinity for the growth-hormone secretagogue receptor.
1. Satoh, M., et al. 1994. J. Pharmacol. Exp. Ther. 271: 574-579. PMID: 7965757
2. Inatomi, N., et al. 1996. Jpn. J. Pharmacol. 71: 29-38. PMID: 8791169
3. Asakawa, A., et al. 2003. J. Gastroenterol. Hepatol. 18: 881-882. PMID: 12795766
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.